A Randomized, Open-label, Single Dose, Cross-over Study to Investigate the Relative Bioavailability of Setrobuvir (STV) Tablet Formulation Versus the Reference Setrobuvir Capsule Formulation Following Oral Administration With or Without a High Fat Meal in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2015
At a glance
- Drugs Setrobuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Roche
- 03 Apr 2013 Actual end date changed from Nov 2012 to Mar 2013 as reported by ClinicalTrials.gov.
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.